Hoth Therapeutics Inc. (NASDAQ: HOTH) provided an update on its clinical pipeline, detailing progress across four therapeutic programs including a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE